Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             141 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A case of Crohn's disease complicated by Adult Onset Still's Disease Rajabally, M.N.
2010
4 p. 475-478
4 p.
artikel
2 A case of EBV driven haemophagocytic lymphohistiocytosis complicating a teenage Crohn's disease patient on azathioprine, successfully treated with rituximab Fitzgerald, Michael P.

4 p. 314-317
artikel
3 Adalimumab as second line anti-tumour necrosis factor alpha therapy for Crohn's disease: A single centre experience Sprakes, Michael B.
2011
4 p. 324-331
8 p.
artikel
4 Adalimumab or infliximab for the prevention or treatment of post-operative recurrence in Crohn's disease Yamamoto, Takayuki

4 p. e157
artikel
5 Adalimumab reversed a severe lymphopenia in a patient with Crohn's disease Taxonera, Carlos

4 p. 488-491
artikel
6 Advanced endoscopic imaging techniques in Crohn's disease Tontini, Gian Eugenio
2014
4 p. 261-269
9 p.
artikel
7 Air pollution: An environmental factor contributing to intestinal disease Beamish, Leigh A.
2011
4 p. 279-286
8 p.
artikel
8 An experimental study on ulcerative colitis as a potential target for probiotic therapy by Lactobacillus acidophilus with or without “olsalazine” Abdin, Amany A.
2008
4 p. 296-303
8 p.
artikel
9 Anterior ischemic optic neuropathy in a patient with Crohn's disease and aberrant MTHFR and GPIIIa gene variants Felekis, T.
2010
4 p. 471-474
4 p.
artikel
10 Anti-TNF-α antibodies improve intestinal barrier function in Crohn's disease Noth, Rainer

4 p. 464-469
artikel
11 Anti-tumor necrosis factor-α induced systemic lupus erythematosus in a patient with metastatic Crohn's disease—what is the role of anti-TNF antibody? Farkas, Klaudia

4 p. e143-e145
artikel
12 Appendiceal adenocarcinoma in a patient with chronic ulcerative colitis: What is the appropriate surgical procedure? Shen, Huafeng
2014
4 p. 334-335
2 p.
artikel
13 Appropriate maintenance treatment for Crohn's disease: Results of a multidisciplinary international expert panel — EPACT II Juillerat, Pascal
2009
4 p. 241-249
9 p.
artikel
14 Appropriate management of special situations in Crohn's disease (upper gastro-intestinal; extra-intestinal manifestations; drug safety during pregnancy and breastfeeding): Results of a multidisciplinary international expert panel—EPACT II Mottet, Christian
2009
4 p. 257-263
7 p.
artikel
15 Appropriateness of therapy for active Crohn's disease: Results of a multidisciplinary international expert panel—EPACT II Michetti, Pierre
2009
4 p. 232-240
9 p.
artikel
16 Appropriate therapy for fistulizing and fibrostenotic Crohn's disease: Results of a multidisciplinary expert panel — EPACT II Felley, Christian
2009
4 p. 250-256
7 p.
artikel
17 A role for B12 in inflammatory bowel disease patients with suppurative dermatoses? An experience with high dose vitamin B12 therapy Mortimore, Marianne
2010
4 p. 466-470
5 p.
artikel
18 Attitudes towards antidepressants among people living with inflammatory bowel disease: An online Australia-wide survey Mikocka-Walus, Antonina
2014
4 p. 296-303
8 p.
artikel
19 A United Kingdom inflammatory bowel disease database: Making the effort worthwhile Bardhan, K.D.
2010
4 p. 405-412
8 p.
artikel
20 Autoimmune polyglandular syndrome type 2, alopecia universalis and Crohn's disease Protic, Marijana

4 p. 318-321
artikel
21 Azathioprine induced pneumonitis in a patient with ulcerative colitis Bodelier, Alexander G.L.
2009
4 p. 309-312
4 p.
artikel
22 Bilberry ingestion improves disease activity in mild to moderate ulcerative colitis — An open pilot study Biedermann, Luc

4 p. 271-279
artikel
23 Clumsy analogy yields melodramatic conclusion: MAP are not weapons of mass destruction Lipton, Judith Eve

4 p. 503
artikel
24 Combination of thiopurines and allopurinol: Adverse events and clinical benefit in IBD Govani, Shail M.
2010
4 p. 444-449
6 p.
artikel
25 Comparing disease activity indices in ulcerative colitis Walsh, A.J.
2014
4 p. 318-325
8 p.
artikel
26 Comprehensive study of cardiovascular morbidity in hospitalized inflammatory bowel disease patients Sridhar, Arun Raghav Mahankali
2011
4 p. 287-294
8 p.
artikel
27 Conception and pregnancy outcome in women with inflammatory bowel disease: A multicentre study from Japan Naganuma, Makoto
2011
4 p. 317-323
7 p.
artikel
28 Concomitant presentation of collagenous sprue and HFE hemochromatosis Parisian, Keely R.
2011
4 p. 369-372
4 p.
artikel
29 Concurrent diagnosis of Crohn's disease and colorectal carcinoma in a young man with abdominal pain Colleran, G.
2008
4 p. 333-336
4 p.
artikel
30 Confocal laser endomicroscopy for prediction of disease relapse in ulcerative colitis: A pilot study Buda, Andrea
2014
4 p. 304-311
8 p.
artikel
31 Considered “negative” for MAP, these results would be very “positive” for tuberculoid leprosy Greenstein, Robert J.
2011
4 p. 373-
1 p.
artikel
32 Construction and validation of a web-based epidemiological database for inflammatory bowel diseases in Europe Burisch, Johan
2011
4 p. 342-349
8 p.
artikel
33 Contents 2010
4 p. v-vi
nvt p.
artikel
34 Contents 2014
4 p. v-vi
nvt p.
artikel
35 Contents 2008
4 p. v-vi
nvt p.
artikel
36 Correlation between serum serotonin and endoscopy inflammation scores in patients with ileal pouches Wang, Yinghong

4 p. e133-e142
artikel
37 Corticosteroids and immunosuppressive therapy influence the result of QuantiFERON TB Gold testing in inflammatory bowel disease patients Helwig, Ulf

4 p. 419-424
artikel
38 Cytomegalovirus ileitis in a patient after liver transplantation-differentiating from de novo IBD Navaneethan, Udayakumar
2011
4 p. 354-359
6 p.
artikel
39 Depression and mucosal proinflammatory cytokines are associated in patients with ulcerative colitis and pouchitis — A pilot study Häuser, Winfried
2011
4 p. 350-353
4 p.
artikel
40 Dermatofibroma in a patient with Crohn's disease: A novel clinical manifestation Beyazit, Yavuz
2010
4 p. 490-491
2 p.
artikel
41 Diagnosis and management of pouch outlet obstruction caused by common anatomical problems after restorative proctocolectomy Wu, Xian-rui
2014
4 p. 270-275
6 p.
artikel
42 Dietary calcium intake in patients with inflammatory bowel disease Vernia, Piero
2014
4 p. 312-317
6 p.
artikel
43 Disappointing results following proctectomy with end-colostomy for anorectal Crohn's disease Yamamoto, Takayuki

4 p. e150
artikel
44 Disease severity does not affect the interval between IBD diagnosis and the development of CRC: Results from two large, Dutch case series Mooiweer, Erik

4 p. 435-440
artikel
45 Disseminated cutaneous herpes simplex infection in a patient with Crohn's disease under azathioprine and steroids: First case report and literature review Santos-Antunes, João
2014
4 p. 326-330
5 p.
artikel
46 Does active smoking really influence the course of Crohn's disease? A retrospective observational study Zabana, Yamile

4 p. 280-285
artikel
47 Does the endoscopic appearance of the ileocecal valve suggest the severity of Crohn's disease in the terminal ileum? Molnár, Tamás
2009
4 p. 287-290
4 p.
artikel
48 Eating the enemy in Crohn's disease Caprilli, Renzo
2010
4 p. 377-383
7 p.
artikel
49 ECCO consensus: Evidence-based use of 6-thioguanine therapy in Crohn's disease? de Boer, Nanne K.H.
2010
4 p. 484-485
2 p.
artikel
50 Effects of corticosteroid therapy on depression and inflammation in ulcerative colitis patients Suvak, Burak
2011
4 p. 375-376
2 p.
artikel
51 Elemental diet therapy for pouchitis following restorative proctocolectomy for ulcerative colitis Yamamoto, Takayuki

4 p. e155
artikel
52 Enteric neuroglial apoptosis in inflammatory bowel diseases Bassotti, Gabrio
2009
4 p. 264-270
7 p.
artikel
53 Enterotoxigenic Clostridium perfringens infection and pediatric patients with inflammatory bowel disease Banaszkiewicz, Aleksandra
2014
4 p. 276-281
6 p.
artikel
54 Factors that modify therapy adherence in patients with inflammatory bowel disease Bermejo, Fernando
2010
4 p. 422-426
5 p.
artikel
55 Frequency of indeterminate colitis in children and adults with IBD — a metaanalysis Prenzel, Freerk
2009
4 p. 277-281
5 p.
artikel
56 Granulomas in Crohn's disease: Are newly discovered genetic variants involved? Mazor, Yoav
2010
4 p. 438-443
6 p.
artikel
57 Herpes simplex virus-1 infection of colonic explants as a model of viral-induced activation of Crohn's disease Silva, Manuel A.

4 p. 454-463
artikel
58 High prevalence of fatigue in inflammatory bowel disease: A case control study Römkens, Tessa E.H.
2011
4 p. 332-337
6 p.
artikel
59 How can we really reduce the morbidity of inflammatory bowel disease — Research on genes and cytokines, or find out the causative factors in the environment? Qin, Xiaofa
2009
4 p. 315-
1 p.
artikel
60 Hypothesis: Increased consumption of emulsifiers as an explanation for the rising incidence of Crohn's disease Roberts, Carol L.

4 p. 338-341
artikel
61 IBD care in Europe: A comparative audit of the inpatient management of Crohn's disease and ulcerative colitis using the national UK IBD audit tool Cassinotti, Andrea
2009
4 p. 291-301
11 p.
artikel
62 Immune response to influenza A/H1N1 vaccine in inflammatory bowel disease patients treated with anti TNF-α agents: Effects of combined therapy with immunosuppressants Andrisani, G.

4 p. 301-307
artikel
63 Incidence and characteristics of the 2009 influenza (H1N1) infections in inflammatory bowel disease patients Naganuma, Makoto

4 p. 308-313
artikel
64 Increased pancreatic enzymes and inflammatory bowel diseases: What correlation? Di Bartolo, C.E.
2011
4 p. 378-379
2 p.
artikel
65 Inflammatory bowel disease and hepatitis B and C in Western Balkans: A referral centre study and review of the literature Katsanos, Konstantinos H.
2010
4 p. 450-465
16 p.
artikel
66 Inflammatory pseudotumor of the liver associated with Crohn's disease Mouelhi, Leila
2009
4 p. 305-308
4 p.
artikel
67 Infliximab for treatment of pyoderma gangrenosum with ulcerative colitis Joob, Beuy

4 p. e153
artikel
68 Infliximab therapy for HIV positive Crohn's disease: A case report Habib, Syed F.
2009
4 p. 302-304
3 p.
artikel
69 Instruction for Authors 2009
4 p. I-II
nvt p.
artikel
70 Instruction for Authors 2011
4 p. I-II
nvt p.
artikel
71 Instructions for Authors 2008
4 p. I-II
nvt p.
artikel
72 Intestinal fibrosis in inflammatory bowel disease — Current knowledge and future perspectives Rieder, Florian
2008
4 p. 279-290
12 p.
artikel
73 Intestinal volvulus and its increased incidence in patients with Cornelia de Lange syndrome Kapoor, Shailendra
2014
4 p. 331-
1 p.
artikel
74 Issue Contents List
4 p. v-vi
artikel
75 Issue Contents list
4 p. v-vi
artikel
76 Issue Contents list 2009
4 p. v-vi
nvt p.
artikel
77 Issue Contents list 2011
4 p. v-vi
nvt p.
artikel
78 Is the efficacy of successful infliximab induction therapy maintained for one year lasting without retreatment in different behavior types of Crohn's disease? Molnár, T.
2008
4 p. 322-326
5 p.
artikel
79 Lack of efficacy of azathioprine in the treatment of axial arthritis complicating Crohn's disease Rispo, Antonio
2008
4 p. 357-358
2 p.
artikel
80 Late-onset ulcerative colitis presenting as filiform polyposis Papathanasopoulos, Athanasios A.
2010
4 p. 488-489
2 p.
artikel
81 Liver abscess of the caudate lobe due to Staphylococcus aureus in an ulcerative colitis patient: First case report Albuquerque, Andreia
2011
4 p. 360-363
4 p.
artikel
82 Long-term outcome in patients with ulcerative colitis treated with intravenous cyclosporine A is determined by previous exposure to thiopurines Walch, Andrea
2010
4 p. 398-404
7 p.
artikel
83 Lower doses of 6-mercaptopurine/azathioprine bring enough clinical efficacy and therapeutic concentration of erythrocyte 6-mercaptopurine metabolite in Japanese IBD patients Komiyama, Takako
2008
4 p. 315-321
7 p.
artikel
84 Management of inflammatory bowel disease with vitamin D: Beyond bone health Narula, Neeraj

4 p. 397-404
artikel
85 Management of loss of response to anti-TNF drugs: Change the dose or change the drug? Van Assche, Gert
2008
4 p. 348-351
4 p.
artikel
86 Managing the long term care of inflammatory bowel disease patients: The cost to European health care providers Buchanan, James
2011
4 p. 301-316
16 p.
artikel
87 Measurement of reticulocyte and red blood cell indices in the evaluation of anemia in inflammatory bowel disease Oustamanolakis, Pantelis
2011
4 p. 295-300
6 p.
artikel
88 Mesalazine in left-sided ulcerative colitis: Efficacy analyses from the PODIUM trial on maintenance of remission and mucosal healing Bokemeyer, Bernd

4 p. 476-482
artikel
89 Methotrexate dose in current ECCO consensus on Crohn's disease Karaca, Cetin
2010
4 p. 483-
1 p.
artikel
90 Methotrexate suspension before pregnancy Silva, Bruno César

4 p. e151
artikel
91 Microinflammation in patients with Crohn's disease in clinical remission Maharshak, Nitsan
2008
4 p. 310-314
5 p.
artikel
92 Monitoring inflammatory bowel disease activity: Clinical activity is judged to be more relevant than endoscopic severity or biomarkers Schoepfer, Alain M.

4 p. 412-418
artikel
93 Mucosal healing and steroid-sparing associated with infliximab for steroid-dependent ulcerative colitis Barreiro-de Acosta, Manuel
2009
4 p. 271-276
6 p.
artikel
94 National estimates of the burden of inflammatory bowel disease among racial and ethnic groups in the United States Nguyen, Geoffrey C.
2014
4 p. 288-295
8 p.
artikel
95 Occurrence of demyelinating diseases after anti-TNFα treatment of inflammatory bowel disease: A Danish Crohn Colitis Database study Andersen, Nynne Nyboe
2008
4 p. 304-309
6 p.
artikel
96 Oesophageal Crohn's disease: A novel approach to managing iatrogenic perforation of an oesophageal Crohn's stricture Patel, Kamal V.
2014
4 p. 332-333
2 p.
artikel
97 Olfactomedin-4 is a glycoprotein secreted into mucus in active IBD Gersemann, Michael

4 p. 425-434
artikel
98 “One more time” 5-ASA retrial after a glucocorticosteroid induced remission in moderate to severe ulcerative colitis: A prospective community practice experience Lipka, Seth

4 p. 342-343
artikel
99 On the second European Panel on the Appropriateness of Crohn's disease Therapy (EPACT-II) Dubois, Robert W.
2009
4 p. 223-224
2 p.
artikel
100 On the zoonosis of M. avium subspecies paratuberculosis (MAP) Greenstein, Robert J.

4 p. 504
artikel
101 Patients with Crohn's disease experience reduced general health and vitality in the chronic stage: Ten-year results from the IBSEN study Høivik, Marte Lie

4 p. 441-453
artikel
102 Penile Crohn's disease resolved by infliximab Lee, Yoon

4 p. e146-e149
artikel
103 Perianal disease in patients with ulcerative colitis: A case-control study Zabana, Yamile
2011
4 p. 338-341
4 p.
artikel
104 Pitfalls and errors in the diagnosis of collagenous and lymphocytic colitis Fernández-Bañares, Fernando
2008
4 p. 343-347
5 p.
artikel
105 Pneumatosis intestinalis and hepatic portal venous gas in Crohn's disease Hokama, Akira
2009
4 p. 313-314
2 p.
artikel
106 Pneumatosis intestinalis and perforation in Crohn's disease: Worrisome or not? Bareggi, Emilia
2014
4 p. 338-339
2 p.
artikel
107 Pneumocystosis in a patient with Crohn's disease treated with combination therapy with adalimumab Desales, Ana L.

4 p. 483-487
artikel
108 Pneumonia due to Nocardia cyriacigeorgica in a patient with Crohn's disease treated with infliximab Parra, M.I.
2008
4 p. 331-332
2 p.
artikel
109 Prescription of physical exercise in Crohn's disease Pérez, Carlos Ayán
2009
4 p. 225-231
7 p.
artikel
110 Prevalence and factors related to hepatitis B and C infection in inflammatory bowel disease patients in China: A retrospective study Huang, Mei Lan
2014
4 p. 282-287
6 p.
artikel
111 Proinflammatory cytokines induce crosstalk between colonic epithelial cells and subepithelial myofibroblasts: Implication in intestinal fibrosis Drygiannakis, Ioannis

4 p. 286-300
artikel
112 Pulmonary diseases associated with inflammatory bowel diseases Casella, Giovanni
2010
4 p. 384-389
6 p.
artikel
113 Pulmonary manifestations of inflammatory bowel disease: Case presentations and review Basseri, Benjamin
2010
4 p. 390-397
8 p.
artikel
114 Recurrent posterior scleritis and orbital myositis as extra-intestinal manifestations of Crohn's disease: Case report and systematic literature review Culver, Emma L.
2008
4 p. 337-342
6 p.
artikel
115 Reply to Dr. Greenstein et al. Letter Ricanek, Petr
2011
4 p. 374-
1 p.
artikel
116 Reply to Dr. Joob et al.'s letter Andrisani, Gianluca

4 p. e154
artikel
117 Reply to Drs. Silva and Santana's letter Van Assche, Gert

4 p. e152
artikel
118 Reply to Dr. Suvak et al.'s letter Häuser, Winfried
2011
4 p. 377-
1 p.
artikel
119 Reply to Dr. Yamamoto's letter Papamichael, Konstantinos

4 p. e158
artikel
120 Reply to Dr. Yamamoto's letter McLaughlin, Simon

4 p. e156
artikel
121 Reply to letters from Dr. Lipton, and Dr. Greenstein et al. Van Kruiningen, Herbert J.

4 p. 505
artikel
122 Report of the ECCO pathogenesis workshop on anti-TNF therapy failures in inflammatory bowel diseases: Definitions, frequency and pharmacological aspects Allez, Matthieu
2010
4 p. 355-366
12 p.
artikel
123 Report of the ECCO workshop on anti-TNF therapy failures in inflammatory bowel diseases: Biological roles and effects of TNF and TNF antagonists Chowers, Yehuda
2010
4 p. 367-376
10 p.
artikel
124 Results of the 2nd scientific workshop of the ECCO (IV): Therapeutic strategies to enhance intestinal healing in inflammatory bowel disease Armuzzi, Alessandro

4 p. 492-502
artikel
125 Revisiting the past: Intra-arterial vasopressin for severe gastrointestinal bleeding in Crohn's disease Alla, Venkata M.B.
2010
4 p. 479-482
4 p.
artikel
126 Severe disease on endoscopy and steroid use increase the risk for bowel perforation during colonoscopy in inflammatory bowel disease patients Navaneethan, Udayakumar

4 p. 470-475
artikel
127 Successful treatment with adalimumab in a familial case of gastrointestinal Behcet's disease De Cassan, Chiara
2011
4 p. 364-368
5 p.
artikel
128 The burden of inflammatory bowel disease in Europe Burisch, Johan

4 p. 322-337
artikel
129 The burden of inpatient costs in inflammatory bowel disease and opportunities to optimize care: A single metropolitan Australian center experience van Langenberg, Daniel R.
2010
4 p. 413-421
9 p.
artikel
130 The complexity of adverse side-effects to biological agents Aubin, François

4 p. 257-262
artikel
131 The effect of third-party reporting on adoption of evidence-based mesalazine regimens in ulcerative colitis: An observational study Kruis, Wolfgang

4 p. e125-e132
artikel
132 The health care cost of intravenous iron treatment in IBD patients depends on the economic evaluation perspective Bager, Palle
2010
4 p. 427-430
4 p.
artikel
133 The pattern and outcome of acute severe colitis Dinesen, Lotte C.
2010
4 p. 431-437
7 p.
artikel
134 The prevalence of hyper- and hypothyroidism in patients with ulcerative colitis Casella, Giovanni
2008
4 p. 327-330
4 p.
artikel
135 Therapeutic dilemmas in patient with perianal Crohn's disease and corticosteroid dependent difficult-to-control asthma Urek, Marija Crnčević
2010
4 p. 486-487
2 p.
artikel
136 The role of capsule endoscopy in small bowel Crohn's disease O'Donnell, S.
2009
4 p. 282-286
5 p.
artikel
137 Th17 immune response in IBD: A new pathogenic mechanism Caprioli, Flavio
2008
4 p. 291-295
5 p.
artikel
138 Unique endoscopic findings of colitis-associated colorectal cancer in a patient with ulcerative colitis and Lynch syndrome Minami, Naoki
2014
4 p. 336-337
2 p.
artikel
139 Use of exclusive enteral nutrition in paediatric Crohn's disease in The Netherlands de Bie, Charlotte

4 p. 263-270
artikel
140 Vitamin D as a therapy for colitis: A systematic review Nicholson, Imogen

4 p. 405-411
artikel
141 Why does Crohn's disease usually occur in terminal ileum? Caprilli, Renzo
2008
4 p. 352-356
5 p.
artikel
                             141 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland